Federated Hermes, Inc. Amneal Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 265,985 shares of AMRX stock, worth $2.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

265,985

Previous 265,534 0.17%

Holding current value

$2.19 Million

Previous $1.69 Million 31.2%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.42 - $8.83 $2,895 - $3,982	451 Added 0.17%	265,985 $2.21 Million
Q2 2024 Aug 08, 2024	SELL	$5.36 - $7.11 $32,176 - $42,681	-6,003 Reduced 2.21%	265,534 $1.69 Million
Q1 2024 May 14, 2024	BUY	$5.24 - $6.34 $1.01 Million - $1.23 Million	193,363 Added 247.35%	271,537 $1.65 Million
Q4 2023 Jan 31, 2024	SELL	$3.36 - $6.21 $285 - $527	-85 Reduced 0.11%	78,174 $474,000
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $215,994 - $359,208	78,259 New	78,259 $330,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $23,547 - $34,890	-7,823 Reduced 50.94%	7,535 $24,000
Q1 2022 May 13, 2022	BUY	$3.9 - $4.89 $74 - $92	19 Added 0.12%	15,358 $64,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $68,591 - $101,585	-17,365 Reduced 53.1%	15,339 $73,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $22,075 - $28,888	5,122 Added 18.57%	32,704 $175,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $25,072 - $33,397	-4,897 Reduced 15.08%	27,582 $141,000
Q1 2021 May 13, 2021	SELL	$4.74 - $7.38 $438,483 - $682,701	-92,507 Reduced 74.01%	32,479 $218,000
Q4 2020 Feb 12, 2021	BUY	$3.95 - $5.42 $6,734 - $9,241	1,705 Added 1.38%	124,986 $572,000
Q3 2020 Nov 12, 2020	BUY	$3.54 - $5.27 $36,104 - $53,748	10,199 Added 9.02%	123,281 $479,000
Q2 2020 Aug 13, 2020	SELL	$2.87 - $5.46 $3.88 Million - $7.38 Million	-1,351,577 Reduced 92.28%	113,082 $538,000
Q1 2020 May 13, 2020	BUY	$2.46 - $5.35 $2.58 Million - $5.61 Million	1,047,868 Added 251.41%	1,464,659 $5.1 Million
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $584,841 - $1.23 Million	220,695 Added 112.54%	416,791 $2.01 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $447,301 - $1.39 Million	195,328 Added 25433.33%	196,096 $568,000
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $682 - $1,514	-106 Reduced 12.13%	768 $6,000
Q1 2019 May 10, 2019	SELL	$11.87 - $14.84 $925 - $1,157	-78 Reduced 8.19%	874 $12,000
Q4 2018 Feb 13, 2019	SELL	$13.09 - $21.49 $1,335 - $2,191	-102 Reduced 9.68%	952 $12,000
Q3 2018 Nov 13, 2018	SELL	$16.4 - $24.27 $2,869 - $4,247	-175 Reduced 14.24%	1,054 $23,000
Q2 2018 Aug 10, 2018	BUY	$13.95 - $20.2 $17,144 - $24,825	1,229 New	1,229 $20,000

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Amneal Pharmaceuticals, Inc. Transaction History